SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Philippe J. Dor who wrote (290)2/14/1997 6:58:00 PM
From: Pete Holm   of 6136
 
With no real information, at about 90-100, the book value (1.2 Billion) of the company equals the value of the outstanding shares (13.5M). This would be a good point to split without a product on the market. I would figure a 3 for 1 because they were releasing shares 6 and more months ago and the stock hung at 30-35 while they were doing it. If they did enough business (400 M), it might go 4 for 1, but not likely.

I don't know about your other questions, but they have 13.5 M outstanding and 100 million shares when they originally filed. About 35% of the stock are held by about 35 institutional customers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News